tiprankstipranks
Reyon Pharmaceutical Co., Ltd. (KR:102460)
:102460
South Korea Market
102460
Reyon Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Reyon Pharmaceutical Co., Ltd. (102460) Financial Statements

― Followers

Reyon Pharmaceutical Co., Ltd. Financial Overview

Reyon Pharmaceutical Co., Ltd.'s market cap is currently ₩182.68B. The company's EPS TTM is ₩-1868.6; its P/E ratio is -5.43; Reyon Pharmaceutical Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 145.93B₩ 148.30B₩ 151.07B₩ 154.04B₩ 142.80B
Gross Profit₩ 33.76B₩ 72.79B₩ 78.90B₩ 81.73B₩ 79.44B
Operating Income₩ -31.57B₩ 79.26M₩ 4.03B₩ 9.63B₩ 3.74B
EBITDA₩ 228.10M₩ 12.76B₩ 9.01B₩ 13.52B₩ 6.21B
Net Income₩ -29.83B₩ 4.15B₩ 3.58B₩ 7.43B₩ 5.54B
Balance Sheet
Cash & Short-Term Investments₩ 6.78B₩ 10.21B₩ 24.24B₩ 36.07B₩ 97.45B
Total Assets₩ 465.05B₩ 499.99B₩ 499.78B₩ 484.69B₩ 477.98B
Total Debt₩ 216.12B₩ 204.05B₩ 225.05B₩ 210.20B₩ 207.31B
Net Debt₩ 209.45B₩ 193.84B₩ 200.95B₩ 194.15B₩ 140.57B
Total Liabilities₩ 244.97B₩ 250.05B₩ 251.15B₩ 236.93B₩ 232.74B
Stockholders' Equity₩ 220.08B₩ 249.94B₩ 248.62B₩ 247.77B₩ 245.24B
Cash Flow
Free Cash Flow₩ -6.69B₩ -17.46B₩ -20.23B₩ -54.40B₩ -105.31B
Operating Cash Flow₩ 1.23B₩ -1.44B₩ 8.65B₩ 8.73B₩ 11.68B
Investing Cash Flow₩ -7.34B₩ -16.59B₩ -8.74B₩ -52.56B₩ -114.68B
Financing Cash Flow₩ 2.36B₩ 4.13B₩ 8.15B₩ -6.77B₩ 157.58B
Currency in KRW

Reyon Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Reyon Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Reyon Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Reyon Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >